These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10100171)

  • 1. 103Pd loaded cartridge air kerma strength verification.
    Mellenberg DE; Pennington EC
    Med Dosim; 1999; 24(1):73-5. PubMed ID: 10100171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Well-ionization chamber response relative to NIST air-kerma strength standard for prostate brachytherapy seeds.
    Mitch MG; Zimmerman BE; Lamperti PJ; Seltzer SM; Coursey BM
    Med Phys; 2000 Oct; 27(10):2293-6. PubMed ID: 11099196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of dose-rate constant for 103Pd seeds with air kerma strength calibration based upon a primary national standard.
    Nath R; Yue N; Shahnazi K; Bongiorni PJ
    Med Phys; 2000 Apr; 27(4):655-8. PubMed ID: 10798685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calibration of multiple LDR brachytherapy sources.
    DeWerd LA; Micka JA; Holmes SM; Bohm TD
    Med Phys; 2006 Oct; 33(10):3804-13. PubMed ID: 17089845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procedures for establishing and maintaining consistent air-kerma strength standards for low-energy, photon-emitting brachytherapy sources: recommendations of the Calibration Laboratory Accreditation Subcommittee of the American Association of Physicists in Medicine.
    DeWerd LA; Huq MS; Das IJ; Ibbott GS; Hanson WF; Slowey TW; Williamson JF; Coursey BM;
    Med Phys; 2004 Mar; 31(3):675-81. PubMed ID: 15070265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations of the American Association of Physicists in Medicine on 103Pd interstitial source calibration and dosimetry: implications for dose specification and prescription.
    Williamson JF; Coursey BM; DeWerd LA; Hanson WF; Nath R; Rivard MJ; Ibbott G
    Med Phys; 2000 Apr; 27(4):634-42. PubMed ID: 10798683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brachytherapy dosimetry of 125I and 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code.
    Bohm TD; DeLuca PM; DeWerd LA
    Med Phys; 2003 Apr; 30(4):701-11. PubMed ID: 12722822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Air-kerma strength determination of a new directional (103)Pd source.
    Aima M; Reed JL; DeWerd LA; Culberson WS
    Med Phys; 2015 Dec; 42(12):7144-52. PubMed ID: 26632069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verification of manufacturer-supplied 125I and 103Pd air-kerma strengths.
    Mellenberg DE; Kline RW
    Med Phys; 1995 Sep; 22(9):1495-7. PubMed ID: 8531880
    [No Abstract]   [Full Text] [Related]  

  • 10. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.
    Rivard MJ; Coursey BM; DeWerd LA; Hanson WF; Huq MS; Ibbott GS; Mitch MG; Nath R; Williamson JF
    Med Phys; 2004 Mar; 31(3):633-74. PubMed ID: 15070264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verification of air-kerma strength of 125I seed for permanent prostate implants in Japan.
    Sumida I; Koizumi M; Takahashi Y; Ogata T; Akino Y; Isohashi F; Konishi K; Yoshioka Y; Inoue T
    Int J Clin Oncol; 2009 Dec; 14(6):525-8. PubMed ID: 19967489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calibration procedures for seeds preloaded in cartridges.
    Brame RS; Cohen GN; Zaider M
    Med Phys; 2006 Aug; 33(8):2765-72. PubMed ID: 16964852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric characteristics, air-kerma strength calibration and verification of Monte Carlo simulation for a new Ytterbium-169 brachytherapy source.
    Perera H; Williamson JF; Li Z; Mishra V; Meigooni AS
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):953-70. PubMed ID: 8138449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Edema-induced increase in tumour cell survival for 125I and 103Pd prostate permanent seed implants--a bio-mathematical model.
    Yue N; Chen Z; Nath R
    Phys Med Biol; 2002 Apr; 47(7):1185-204. PubMed ID: 11996063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an automated seed loader for seed calibration in prostate brachytherapy.
    Wan S; Joshi CP; Carnes G; Schreiner LJ
    J Appl Clin Med Phys; 2006; 7(1):115-25. PubMed ID: 16518323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimum timing for image-based dose evaluation of 125I and 103PD prostate seed implants.
    Yue N; Chen Z; Peschel R; Dicker AP; Waterman FM; Nath R
    Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):1063-72. PubMed ID: 10571216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some treatment planning considerations for 103Pd and 125I permanent interstitial implants.
    Nath R; Meigooni AS; Melillo A
    Int J Radiat Oncol Biol Phys; 1992; 22(5):1131-8. PubMed ID: 1555965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monte Carlo-aided dosimetry of the theragenics TheraSeed model 200 103Pd interstitial brachytherapy seed.
    Monroe JI; Williamson JF
    Med Phys; 2002 Apr; 29(4):609-21. PubMed ID: 11991133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric consideration of individual 125I source strength measurement and a large-scale comparison of that measured with a nominal value in permanent prostate implant brachytherapy.
    Takahashi Y; Ito A; Sumida I; Kozuka T; Gomi K; Nose T; Ito T; Yamashita T
    Radiat Med; 2006 Dec; 24(10):675-9. PubMed ID: 17186322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose rate constant and energy spectrum of interstitial brachytherapy sources.
    Chen Z; Nath R
    Med Phys; 2001 Jan; 28(1):86-96. PubMed ID: 11213926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.